Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Ulcerative Colitis Market Report 2024

Ulcerative Colitis Global Market Report 2025 – By Drug Type (Anti-Inflammatory Drugs, Anti-TNF Biologics, Immunosuppressant, Calcineurin Inhibitors, Other Drug Types), By Disease Type (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, Fulminant Colitis), By Molecule Type (Biologics, Small Molecules), By Route of Administration (Oral, Injectables), By End-User (Hospital Pharmacies, Retail Pharmacies, Drug Store, Other End-User) – Market Size, Trends, And Global Forecast 2025-2034

Ulcerative Colitis Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Ulcerative Colitis Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Ulcerative Colitis Market Definition

Ulcerative colitis is a chronic inflammatory bowel disease (IBD) and is categorized as an autoimmune disorder in which the immune system attacks healthy tissue of the large intestine and causes inflammation on the superficial layer of the large intestine. It includes symptoms of diarrhea, weight loss, abdominal cramping, anemia, blood or pus in bowel movements, and others.

The main types of drugs for ulcerative colitis are anti-inflammatory drugs, anti-TNF biologics, immunosuppressants, calcineurin inhibitors, and others. Anti-inflammatory drugs refer to a drug or substance that reduces inflammation (redness, swelling, and pain) in the body. These are prescribed for various diseases such as ulcerative proctitis, proctosigmoiditis, left-sided colitis, pancolitis or universal colitis, and fulminant colitis, with molecule types including biologics and small molecules, which can be administered orally or injectable. It is used by various end-users, including hospital pharmacies, retail pharmacies, drug stores, and others.

Ulcerative Colitis Market Segmentation

The ulcerative colitis market covered in this report is segmented –

1) By Drug Type: Anti-Inflammatory Drugs, Anti-TNF Biologics, Immunosuppressant, Calcineurin Inhibitors, Other Drug Types

2) By Disease Type: Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, Fulminant Colitis

3) By Molecule Type: Biologics, Small Molecules

4) By Route of Administration: Oral, Injectables

5) By End-User: Hospital Pharmacies, Retail Pharmacies, Drug Store, Other End-User

Subsegments:

1) By Anti-Inflammatory Drugs: Aminosalicylates, corticosteroids

2) By Anti-TNF Biologics: Infliximab, Adalimumab, Golimumab

3) By Immunosuppressant: Azathioprine, Mercaptopurine

4) By Calcineurin Inhibitors: tacrolimus, Cyclosporine

5) By Other Drug Types: JAK Inhibitors, Monoclonal Antibodies, Other Novel Therapies

Ulcerative Colitis Market Size and growth rate 2025 to 2029: Graph

Ulcerative Colitis Market Size 2025 And Growth Rate

The ulcerative colitis market size has grown strongly in recent years. It will grow from$7.39 billion in 2024 to $7.89 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to prevalence of ulcerative colitis, innovations in drug development, biologics and targeted therapies, improved treatment guidelines, patient advocacy and support groups

Ulcerative Colitis Market Growth Forecast

The ulcerative colitis market size is expected to see strong growth in the next few years. It will grow to $10.36 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to advancements in telemedicine, focus on early intervention, biosimilars market growth, research in gut microbiome, emergence of novel therapies. Major trends in the forecast period include patient-centric approaches, global collaborations in research, integration of digital health solutions, innovations in drug delivery, topical and localized therapies.

Book your 30 minutes free consultation with our research experts

Contact Us

Ulcerative Colitis Market Driver: Fueling Growth Ulcerative Colitis Market Expands With The Surge In Healthcare Expenditure

The increasing healthcare expenditure is expected to propel the growth of the ulcerative colitis market going forward. Health expenditure refers to all spending for health-related services, family planning activities, nutrition activities, and emergency help, but excludes expenses for drinking water and sanitation. Increased healthcare spending can benefit ulcerative colitis sufferers by improving access to medical care and therapies. Hospitalization for ulcerative colitis can be significant, and hospital readmissions for flares can result in higher mortality and healthcare costs. For instance, in March 2022, according to the 2021–2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based Department of Health and Human Services department, the annual increase in national health spending was predicted to average 5.1% between 2021 and 2030, reaching approximately $6.8 trillion by 2030. Additionally, throughout the period 2021–2030, Medicare expenditures are expected to expand at a 7.2% annual rate, while Medicaid spending is expected to grow at a 5.6% annual rate. Therefore, increasing healthcare expenditures are driving the growth of the ulcerative colitis market.

Ulcerative Colitis Market Driver: Navigating Growth Rising Prevalence And Incidence Fuel Expansion Of Ulcerative Colitis Market

The increasing prevalence and incidence of ulcerative colitis are expected to propel the growth of the ulcerative colitis market in the coming future. Ulcerative colitis is a chronic inflammatory bowel disease (IBD) that primarily impacts the colon and rectum, marked by ulcers and inflammation in the lining of the large intestine (colon) and rectum, resulting in a variety of symptoms and problems. The growing incidence and prevalence of ulcerative colitis serve as stimulants, encouraging innovation, expansion, and an emphasis on bettering patient outcomes. For instance, in January 2022, according to Crohn’s & Colitis Australia, an Australia-based non-profit organization that provides people with inflammatory bowel disease support, guidance, and encouragement, Australia is projected to have between 100,000 and 160,000 patients with Crohn's disease and ulcerative colitis by 2022. Therefore, the increasing prevalence and incidence of ulcerative colitis are driving the ulcerative colitis market.

Global Ulcerative Colitis Market Major Players

Major companies operating in the ulcerative colitis market include AbbVie Inc., AstraZeneca plc, Bausch Health Companies Inc., Eli Lilly and Co., Johnson & Johnson, Index Pharmaceuticals Holdings AB, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Allergan plc, Bayer AG, BioLineRx Ltd., Celgene Corporation, Bristol Myers Squib Company, Takeda Pharmaceutical Company Limited, Genentech Inc., UCB S.A., Protagonist Therapeutics, Shire plc, Prometheus Laboratories Inc., Cosmo Pharmaceuticals, Dr. Falk Pharma GmbH, Tillotts Pharma AG, Ferring Pharmaceuticals Inc., Salix Pharmaceuticals Inc.

Global Ulcerative Colitis Market Trend: Revolutionizing IBD Diagnosis Clario Ert Inc., Gi Reviewers LLC, And Rsip Vision Unveil AI Technology For Enhanced Ulcerative Colitis Scoring

Technological advancements are a key trend gaining popularity in the ulcerative colitis market. Companies operating in the ulcerative colitis market are adopting new technologies to sustain their position in the market. For instance, in March 2023, Clario ERT Inc., a US-based healthcare research and technology firm, and GI Reviewers LLC, a US-based pharmaceutical reviews and assessment organization, along with RSIP Vision, an ISRAEL-based software company, released their innovative and human-level AI technology-based rating system to improve efficiency and consistency of inflammatory bowel disease (IBD) scoring, such as ulcerative colitis (UC) and Crohn’s disease scoring. The method is projected to enhance the repeatability of colonoscopy video scoring, streamline workflow by reducing the time necessary for a human expert reader to score, and, eventually, boost recruitment and lower clinical trial expenses. The performance of algorithms, as measured by the Kappa metric technology, was shown to be equivalent to that of human reviewers. The algorithm was trained on hundreds of films from various sites and devices, comprising over 100,000 photos, all of which were assessed by an expert gastroenterologist.

Global Ulcerative Colitis Market Trend: Sanofi S.A. And Teva Pharmaceuticals Forge Strategic Partnership To Advance Tev'574 In The Treatment Of Crohn's Disease And Ulcerative Colitis

Major companies operating in the ulcerative colitis market are adopting a strategic partnership approach aiming to jointly develop and market pharmaceuticals that are presently being developed. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in October 2023, Sanofi S.A., a France-based healthcare and pharmaceutical company, announced a partnership with Teva Pharmaceuticals to jointly develop and market the asset TEV'574, which is presently undergoing Phase 2b clinical studies to treat Crohn's disease and ulcerative colitis, two forms of inflammatory bowel illness. Teva will be paid an upfront payment of €469 million ($500 million) and up to €940 million ($1 billion) in milestones related to development and commercialization under the provisions of the new collaboration agreement. Sanofi will spearhead the development of the Phase 3 program, and all companies will equally split the development costs worldwide as well as net earnings and losses in important markets. Sanofi will manage North American, Japanese, other Asian, and worldwide product commercialization; Teva will lead the charge in Europe, Israel, and a few other nations. Teva Pharmaceuticals is a US-based subsidiary company of Teva Pharmaceutical Industries Ltd., an Israeli pharmaceutical company.

Ulcerative Colitis Market Merger And Acquisition: Pfizer Inc. Expands Inflammation And Immunology Portfolio With Acquisition Of Arena Pharmaceuticals Inc.

In March 2022, Pfizer Inc., a US-based biopharmaceutical company, acquired Arena Pharmaceuticals Inc. for approximately $6.7 billion. This acquisition aims to expand Pfizer's existing inflammation and immunology pipeline portfolio of drugs into its inflammation and immunology therapeutic area, which will aid in the goal of generating breakthroughs to improve the lives of people suffering from immuno-inflammatory disorders. Arena Pharmaceuticals Inc. is a US-based biopharmaceutical company and developer of Etrasimod, a highly selective, once-daily oral sphingosine 1-phosphate (S1P) receptor modulator that is used for the treatment of ulcerative colitis, Crohn’s disease, and others.

Regional Analysis For The Global Ulcerative Colitis Market

North America was the largest region in the ulcerative colitis market in 2024. The regions covered in the ulcerative colitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the ulcerative colitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Ulcerative Colitis Market?

The ulcerative colitis market consists of sales of aminosalicylates and corticosteroids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Ulcerative Colitis Industry?

The ulcerative colitis market research report is one of a series of new reports from The Business Research Company that provides ulcerative colitis market statistics, including ulcerative colitis industry global market size, regional shares, competitors with an ulcerative colitis market share, detailed ulcerative colitis market segments, market trends and opportunities, and any further data you may need to thrive in the ulcerative colitis industry. This ulcerative colitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Ulcerative Colitis Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $7.89 billion
Revenue Forecast In 2034 $10.36 billion
Growth Rate CAGR of 7.0% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Type: Anti-Inflammatory Drugs, Anti-TNF Biologics, Immunosuppressant, Calcineurin Inhibitors, Other Drug Types
2) By Disease Type: Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, Fulminant Colitis
3) By Molecule Type: Biologics, Small Molecules
4) By Route of Administration: Oral, Injectables
5) By End-User: Hospital Pharmacies, Retail Pharmacies, Drug Store, Other End-User Subsegments: 1) By Anti-Inflammatory Drugs: Aminosalicylates, Corticosteroids
2) By Anti-TNF Biologics: Infliximab, Adalimumab, Golimumab
3) By Immunosuppressant: Azathioprine, Mercaptopurine
4) By Calcineurin Inhibitors: Tacrolimus, Cyclosporine
5) By Other Drug Types: JAK Inhibitors, Monoclonal Antibodies, Other Novel Therapies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled AbbVie Inc., AstraZeneca plc, Bausch Health Companies Inc., Eli Lilly and Co., Johnson & Johnson, Index Pharmaceuticals Holdings AB, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Allergan plc, Bayer AG, BioLineRx Ltd., Celgene Corporation, Bristol Myers Squib Company, Takeda Pharmaceutical Company Limited, Genentech Inc., UCB S.A., Protagonist Therapeutics, Shire plc, Prometheus Laboratories Inc., Cosmo Pharmaceuticals, Dr. Falk Pharma GmbH, Tillotts Pharma AG, Ferring Pharmaceuticals Inc., Salix Pharmaceuticals Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Ulcerative Colitis Market Characteristics

    3. Ulcerative Colitis Market Trends And Strategies

    4. Ulcerative Colitis Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

    5. Global Ulcerative Colitis Growth Analysis And Strategic Analysis Framework

    5.1. Global Ulcerative Colitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Ulcerative Colitis Market Growth Rate Analysis

    5.4. Global Ulcerative Colitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Ulcerative Colitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Ulcerative Colitis Total Addressable Market (TAM)

    6. Ulcerative Colitis Market Segmentation

    6.1. Global Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Anti-Inflammatory Drugs

    Anti-TNF Biologics

    Immunosuppressant

    Calcineurin Inhibitors

    Other Drug Types

    6.2. Global Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Ulcerative Proctitis

    Proctosigmoiditis

    Left-sided Colitis

    Pancolitis or Universal Colitis

    Fulminant Colitis

    6.3. Global Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Biologics

    Small Molecules

    6.4. Global Ulcerative Colitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oral

    Injectables

    6.5. Global Ulcerative Colitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Drug Store

    Other End-User

    6.6. Global Ulcerative Colitis Market, Sub-Segmentation Of Anti-Inflammatory Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Aminosalicylates

    Corticosteroids

    6.7. Global Ulcerative Colitis Market, Sub-Segmentation Of Anti-TNF Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Infliximab

    Adalimumab

    Golimumab

    6.8. Global Ulcerative Colitis Market, Sub-Segmentation Of Immunosuppressant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Azathioprine

    Mercaptopurine

    6.9. Global Ulcerative Colitis Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Tacrolimus

    Cyclosporine

    6.10. Global Ulcerative Colitis Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    JAK Inhibitors

    Monoclonal Antibodies

    Other Novel Therapies

    7. Ulcerative Colitis Market Regional And Country Analysis

    7.1. Global Ulcerative Colitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Ulcerative Colitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Ulcerative Colitis Market

    8.1. Asia-Pacific Ulcerative Colitis Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Ulcerative Colitis Market

    9.1. China Ulcerative Colitis Market Overview

    9.2. China Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Ulcerative Colitis Market

    10.1. India Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Ulcerative Colitis Market

    11.1. Japan Ulcerative Colitis Market Overview

    11.2. Japan Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Ulcerative Colitis Market

    12.1. Australia Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Ulcerative Colitis Market

    13.1. Indonesia Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Ulcerative Colitis Market

    14.1. South Korea Ulcerative Colitis Market Overview

    14.2. South Korea Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Ulcerative Colitis Market

    15.1. Western Europe Ulcerative Colitis Market Overview

    15.2. Western Europe Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Ulcerative Colitis Market

    16.1. UK Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Ulcerative Colitis Market

    17.1. Germany Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Ulcerative Colitis Market

    18.1. France Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Ulcerative Colitis Market

    19.1. Italy Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Ulcerative Colitis Market

    20.1. Spain Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Ulcerative Colitis Market

    21.1. Eastern Europe Ulcerative Colitis Market Overview

    21.2. Eastern Europe Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Ulcerative Colitis Market

    22.1. Russia Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Ulcerative Colitis Market

    23.1. North America Ulcerative Colitis Market Overview

    23.2. North America Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Ulcerative Colitis Market

    24.1. USA Ulcerative Colitis Market Overview

    24.2. USA Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Ulcerative Colitis Market

    25.1. Canada Ulcerative Colitis Market Overview

    25.2. Canada Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Ulcerative Colitis Market

    26.1. South America Ulcerative Colitis Market Overview

    26.2. South America Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Ulcerative Colitis Market

    27.1. Brazil Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Ulcerative Colitis Market

    28.1. Middle East Ulcerative Colitis Market Overview

    28.2. Middle East Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Ulcerative Colitis Market

    29.1. Africa Ulcerative Colitis Market Overview

    29.2. Africa Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Ulcerative Colitis Market Competitive Landscape And Company Profiles

    30.1. Ulcerative Colitis Market Competitive Landscape

    30.2. Ulcerative Colitis Market Company Profiles

    30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Eli Lilly and Co. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

    31. Ulcerative Colitis Market Other Major And Innovative Companies

    31.1. Index Pharmaceuticals Holdings AB

    31.2. GlaxoSmithKline plc

    31.3. Merck & Co. Inc.

    31.4. Novartis AG

    31.5. Pfizer Inc.

    31.6. Sanofi S.A.

    31.7. Allergan plc

    31.8. Bayer AG

    31.9. BioLineRx Ltd.

    31.10. Celgene Corporation

    31.11. Bristol Myers Squib Company

    31.12. Takeda Pharmaceutical Company Limited

    31.13. Genentech Inc.

    31.14. UCB S.A.

    31.15. Protagonist Therapeutics

    32. Global Ulcerative Colitis Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Ulcerative Colitis Market

    34. Recent Developments In The Ulcerative Colitis Market

    35. Ulcerative Colitis Market High Potential Countries, Segments and Strategies

    35.1 Ulcerative Colitis Market In 2029 - Countries Offering Most New Opportunities

    35.2 Ulcerative Colitis Market In 2029 - Segments Offering Most New Opportunities

    35.3 Ulcerative Colitis Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Ulcerative Colitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Ulcerative Colitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Ulcerative Colitis Market, Sub-Segmentation Of Anti-Inflammatory Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Ulcerative Colitis Market, Sub-Segmentation Of Anti-TNF Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Ulcerative Colitis Market, Sub-Segmentation Of Immunosuppressant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Ulcerative Colitis Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Ulcerative Colitis Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Ulcerative Colitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Ulcerative Colitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: AbbVie Inc. Financial Performance
  • Table 82: AstraZeneca plc Financial Performance
  • Table 83: Bausch Health Companies Inc. Financial Performance
  • Table 84: Eli Lilly and Co. Financial Performance
  • Table 85: Johnson & Johnson Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Ulcerative Colitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Ulcerative Colitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Ulcerative Colitis Market, Sub-Segmentation Of Anti-Inflammatory Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Ulcerative Colitis Market, Sub-Segmentation Of Anti-TNF Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Ulcerative Colitis Market, Sub-Segmentation Of Immunosuppressant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Ulcerative Colitis Market, Sub-Segmentation Of Calcineurin Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Ulcerative Colitis Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Ulcerative Colitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Ulcerative Colitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Ulcerative Colitis Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Ulcerative Colitis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Ulcerative Colitis Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: AbbVie Inc. Financial Performance
  • Figure 82: AstraZeneca plc Financial Performance
  • Figure 83: Bausch Health Companies Inc. Financial Performance
  • Figure 84: Eli Lilly and Co. Financial Performance
  • Figure 85: Johnson & Johnson Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the clinical chemistry market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Read More

Dashboard Camera Global Market Report 2025 – By Type (1-Channel, 2-Channel, 3-Channel, Rear View), By Technology (Basic, Advanced, Smart), By Application (Commercial Vehicle, Personal Vehicle) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Automotive Camera Global Market Report 2025 – By Vehicle Type (Passenger Vehicle, Light Commercial Vehicle, Heavy Commercial Vehicle), By View Type (Single View System, Multi Camera System), By Technology (Digital Cameras, Infrared Cameras, Thermal Cameras), By Application (Park Assist, Advanced Driver-Assistance Systems) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Action Camera Global Market Report 2025 – By Type (Box Style, Cube Style, Bullet Style, Periscope & 360°, Other Types), By Resolution Type (Full HD, HD, Ultra HD, Other Resolutions), By Distribution Channel (Brand Outlets, Supermarkets/Hypermarkets, E-Commerce, Specialty Stores), By Application (Sports, Travel And Tourism, Recreational Activities, Entertainment And Media, Automotive, Emergency Services, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Surveillance Technology Global Market Report 2025 – By Technology (Video Surveillance, Big Data, Police Body Cameras, Biometrics, Domestic Drones, Face Recognition Technology, RFID Chips, Stingray Tracking Devices), By Storage (On-Premise, Cloud), By End-User (BFSI (Banking, Financial Services And Insurance), Government, Healthcare, Manufacturing, Retail, IT And Telecommunication, Media And Entertainment, Education, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Video Equipment Global Market Report 2025 – By Product Type (Television, Video Cameras, Video Players), By Application (Online, Offline), By End Use Industry (B2B, B2C) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Video Conferencing Global Market Report 2025 – By Conference Type (Telepresence, Integrated, Desktop, Service-Based Video Conferencing System), By Deployment (Cloud, On-Premises), By Enterprise Size (Small And Medium Enterprises, Large Enterprises), By End-Use (Corporate, Education, BFSI, Media And Entertainment, Government And Defense, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Video Processing Platform Global Market Report 2025 – By Component (Hardware, Platform, Services), By Deployment Type (Public Cloud, Private Cloud, Hybrid), By Application (Video Upload And Ingestion, Dynamic Ad Insertion, Video Transcoding And Processing, Video Hosting, Content Rendering, Other Applications), By Industry (Media And Entertainment, Defense, Government Or Homeland Security, Other Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Electrical And Electronics Global Market Report 2025 – By Type (Electrical Equipment, Measuring and Control Instruments, Electronic Products), By Mode (Online, Offline), By Sales Channel (OEM, Aftermarket), By End-Use (B2B, B2C) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Ulcerative Colitis market?

Ulcerative colitis is a chronic inflammatory bowel disease (IBD) and is categorized as an autoimmune disorder in which the immune system attacks healthy tissue of the large intestine and causes inflammation on the superficial layer of the large intestine. It includes symptoms of diarrhea, weight loss, abdominal cramping, anemia, blood or pus in bowel movements, and others. For further insights on the Ulcerative Colitis market, request a sample here

How will the Ulcerative Colitis market drivers and restraints affect the market dynamics? What forces will shape the Ulcerative Colitis industry going forward?

The Ulcerative Colitis market major growth driver - Fueling Growth Ulcerative Colitis Market Expands With The Surge In Healthcare Expenditure. For further insights on the Ulcerative Colitis market, request a sample here

What is the forecast market size or the forecast market value of the Ulcerative Colitis market?

The Ulcerative Colitis market size has grown strongly in recent years. The ulcerative colitis market size has grown strongly in recent years. It will grow from$7.39 billion in 2024 to $7.89 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to prevalence of ulcerative colitis, innovations in drug development, biologics and targeted therapies, improved treatment guidelines, patient advocacy and support groups The ulcerative colitis market size is expected to see strong growth in the next few years. It will grow to $10.36 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to advancements in telemedicine, focus on early intervention, biosimilars market growth, research in gut microbiome, emergence of novel therapies. Major trends in the forecast period include patient-centric approaches, global collaborations in research, integration of digital health solutions, innovations in drug delivery, topical and localized therapies. For further insights on the Ulcerative Colitis market, request a sample here

How is the Ulcerative Colitis market segmented?

The ulcerative colitis market covered in this report is segmented –
1) By Drug Type: Anti-Inflammatory Drugs, Anti-TNF Biologics, Immunosuppressant, Calcineurin Inhibitors, Other Drug Types
2) By Disease Type: Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, Fulminant Colitis
3) By Molecule Type: Biologics, Small Molecules
4) By Route of Administration: Oral, Injectables
5) By End-User: Hospital Pharmacies, Retail Pharmacies, Drug Store, Other End-User Subsegments:
1) By Anti-Inflammatory Drugs: Aminosalicylates, Corticosteroids
2) By Anti-TNF Biologics: Infliximab, Adalimumab, Golimumab
3) By Immunosuppressant: Azathioprine, Mercaptopurine
4) By Calcineurin Inhibitors: Tacrolimus, Cyclosporine
5) By Other Drug Types: JAK Inhibitors, Monoclonal Antibodies, Other Novel Therapies For further insights on the Ulcerative Colitis market, request a sample here

Which region has the largest share of the Ulcerative Colitis market? What are the other regions covered in the report?

North America was the largest region in the ulcerative colitis market in 2024. The regions covered in the ulcerative colitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Ulcerative Colitis market, request a sample here.

Who are the major players in the Ulcerative Colitis market?

Major companies operating in the ulcerative colitis market include AbbVie Inc., AstraZeneca plc, Bausch Health Companies Inc., Eli Lilly and Co., Johnson & Johnson, Index Pharmaceuticals Holdings AB, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Allergan plc, Bayer AG, BioLineRx Ltd., Celgene Corporation, Bristol Myers Squib Company, Takeda Pharmaceutical Company Limited, Genentech Inc., UCB S.A., Protagonist Therapeutics, Shire plc, Prometheus Laboratories Inc., Cosmo Pharmaceuticals, Dr. Falk Pharma GmbH, Tillotts Pharma AG, Ferring Pharmaceuticals Inc., Salix Pharmaceuticals Inc. . For further insights on the Ulcerative Colitis market, request a sample here.

What are the key trends in the Ulcerative Colitis market?

Major trends in the Ulcerative Colitis market include Revolutionizing IBD Diagnosis Clario Ert Inc., Gi Reviewers LLC, And Rsip Vision Unveil AI Technology For Enhanced Ulcerative Colitis Scoring. For further insights on the Ulcerative Colitis market, request a sample here.

What are the major opportunities in the Ulcerative Colitis market? What are the strategies for the Ulcerative Colitis market?

For detailed insights on the major opportunities and strategies in the Ulcerative Colitis market, request a sample here.

How does the Ulcerative Colitis market relate to the overall economy and other similar markets?

For detailed insights on Ulcerative Colitis's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Ulcerative Colitis industry?

For detailed insights on the mergers and acquisitions in the Ulcerative Colitis industry, request a sample here.

What are the key dynamics influencing the Ulcerative Colitis market growth? SWOT analysis of the Ulcerative Colitis market.

For detailed insights on the key dynamics influencing the Ulcerative Colitis market growth and SWOT analysis of the Ulcerative Colitis industry, request a sample here.